Oyen, Wim J.G.
Humanitas University,
Italy
2025 Rank: 83144
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Nuclear Medicine & Medical Imaging
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 644 out of 122662 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 83144 | 83856 |
| Total Cites | 37916 | 43971 |
| H-index | 90 | 98 |
| Hm-index | 36 | 40 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 44 | 44 |
| Total Cites to Single+First Authored Papers | 934 | 1106 |
| Number of Single+First+Last Authored Papers | 201 | 201 |
| Total Cites to Single+First+Last Authored Papers | 7081 | 7916 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 29564 | 32476 |
| Ratio of Total Citations to Distinct Citing Papers | 1.28 | 1.35 |
| Self-Citation Percentage |
13.77%
|
|
Oyen, Wim J.G.
Rijnstate Hospital,
Netherlands
2024 Rank: 79789
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Nuclear Medicine & Medical Imaging
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 624 out of 116246 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 79789 | 79415 |
| Total Cites | 35303 | 41074 |
| H-index | 87 | 96 |
| Hm-index | 35 | 39 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 44 | 44 |
| Total Cites to Single+First Authored Papers | 918 | 1091 |
| Number of Single+First+Last Authored Papers | 199 | 199 |
| Total Cites to Single+First+Last Authored Papers | 6830 | 7648 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 27348 | 30071 |
| Ratio of Total Citations to Distinct Citing Papers | 1.29 | 1.37 |
| Self-Citation Percentage |
14.05%
|
|
Oyen, Wim J.G.
Radboud University Medical Center,
Netherlands
2023 Rank: 75824
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Nuclear Medicine & Medical Imaging
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 602 out of 109758 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 75824 | 76345 |
| Total Cites | 32650 | 38169 |
| H-index | 84 | 93 |
| Hm-index | 35 | 38 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 44 | 44 |
| Total Cites to Single+First Authored Papers | 904 | 1077 |
| Number of Single+First+Last Authored Papers | 197 | 197 |
| Total Cites to Single+First+Last Authored Papers | 6581 | 7389 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 25089 | 27650 |
| Ratio of Total Citations to Distinct Citing Papers | 1.30 | 1.38 |
| Self-Citation Percentage |
14.46%
|
|
Oyen, Wim J.G.
Radboud University Nijmegen Medical Centre,
Netherlands
2021 Rank: 71621
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Nuclear Medicine & Medical Imaging
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 584 out of 101860 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 71621 | 72372 |
| Total Cites | 27850 | 32693 |
| H-index | 79 | 85 |
| Hm-index | 33 | 36 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 43 | 43 |
| Total Cites to Single+First Authored Papers | 860 | 1031 |
| Number of Single+First+Last Authored Papers | 193 | 193 |
| Total Cites to Single+First+Last Authored Papers | 5943 | 6711 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 21222 | 23362 |
| Ratio of Total Citations to Distinct Citing Papers | 1.31 | 1.40 |
| Self-Citation Percentage |
14.81%
|
|